Transgene Biotek Ltd
company logo

Transgene Biotek Ltd

Transgene Biotek Share Price

Healthcare
Small Cap

-

0 (0%)

Invest in Transgene Biotek Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Transgene Biotek Ltd Performance

-

-

-

-


-

-

-

-

-

Transgene Biotek Ltd Fundamentals

Read More

49.25Cr

0

4.55

1.23

0

0%

1.43

Transgene Biotek Ltd Financials

Transgene Biotek Ltd Financialsright-arrow

Transgene Biotek Ltd Shareholding Pattern

Transgene Biotek Ltd Delivery and Volume

About Transgene Biotek Ltd

Founded in March, 1990 by Dr. Koteswara Rao, Transgene Biotek Ltd was one of the first Biotechnology companies in India. Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology ,

K Koteswara Rao

1990

-

NameDesignation
Sujana KadiamIndependent Director
Ankita JainCompany Sec. & Compli. Officer
Santosh KumarIndependent Director
K Koteswara RaoChairman & Managing Director
Marri SwethaIndependent Director
News and Events...

Similar Stocks

What's Trending

View All
View All

Transgene Biotek Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Transgene Biotek Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Transgene Biotek Ltd's share price is ₹6.5 as of 2024-11-22.
Transgene Biotek Ltd's P/E ratio is - times as of 2024-11-22.
Transgene Biotek Ltd's most recent financial reports indicate a price-to-book ratio of 4.55, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Transgene Biotek Ltd's market capitalization is ₹49.25 Cr as on 2024-11-22.
The current financial records of Transgene Biotek Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Transgene Biotek Ltd's most recent financial filings, the company has a total asset value of ₹1.1, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Transgene Biotek Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Transgene Biotek Ltd's 52-week high and low as of 2024-11-22 are ₹6.78 and ₹6.21, respectively.